Endoscopic Extirpation of Benign Breast Tumors Using a Lateral Chest Wall Incision

June 23, 2024 updated by: Jinghua Zhao, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

The Feasibility Analysis of Endoscopic Extirpation of Benign Breast Tumors Using Lateral Chest Wall Incision: The Feasibility Analysis of Minimally Invasive Excision for Benign Breast Tumors Via Lateral Chest Wall Approach

  1. A new surgical method for breast surgery has been introduced, which involves the removal of benign breast tumors through endoscopic surgery, thereby avoiding noticeable scarring on the breast.
  2. The feasibility of this surgery, key technical points, and potential complications have been analyzed.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

42

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • China
    • Guangdong
      • Guangzhou, Guangdong, China, 510000
        • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The study population consisted of patients diagnosed with benign breast tumors. The demographic characteristics included:

Age: Patients aged 14-42 years old Gender: Female Ethnicity: Diverse ethnic backgrounds, primarily Han Chinese

Inclusion Criteria:

  1. Female breast benign tumor patients
  2. Received endoscopic resection of benign breast tumors via a lateral chest wall approach.

Exclusion Criteria:

Patients who are unable to comply with follow-up requirements

Sample Size:

A total of 42 patients were included in the study

Geographical Location:

Patients were recruited from Sun Yat-sen Memorial Hospital of Sun Yat-sen University

Description

Inclusion Criteria:

  1. Female breast benign tumor patients
  2. Received endoscopic resection of benign breast tumors via a lateral chest wall approach.

Exclusion Criteria:

  1. Patients who are unable to comply with follow-up requirements
  2. Patients with a history of breast sugery
  3. Breast cancer patients

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
observation group
Other: No intervention
No intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cosmetic Outcome After Endoscopic Benign Breast Tumor Resection
Time Frame: 1-3 months post-surgery.
Through outpatient questionnaires and physician-rated photo evaluations
1-3 months post-surgery.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2021

Primary Completion (Actual)

August 31, 2023

Study Completion (Actual)

November 30, 2023

Study Registration Dates

First Submitted

June 15, 2024

First Submitted That Met QC Criteria

June 23, 2024

First Posted (Actual)

June 25, 2024

Study Record Updates

Last Update Posted (Actual)

June 25, 2024

Last Update Submitted That Met QC Criteria

June 23, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SunYatsenU8H

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe